儿科败血性关节炎的在线患者教育材料超过了推的阅读水平:可读性分析
Nicholas J Pettinelli1,2, Madison C Blackwell2, Mark Schwartz3
1Trauma Institute, Saint Francis Health System, Tulsa, USA.
Cureus
|February 16, 2026
概括
关于儿科败血性关节炎的患者教育材料往往超过推的可读性水平,阻碍了家庭获得关键的骨科紧急信息. 改善这些材料对于健康公平至关重要.
科学领域:
- 整形外科 整形外科 整形外科
- 儿科医学 儿科医学
- 卫生沟通健康沟通
背景情况:
- 儿科败血性关节炎是一个关键的骨科紧急情况,需要及时诊断和治疗.
- 可访问的患者教育材料 (PEMs) 对寻求有关这种情况的信息的家庭至关重要.
- 现有的骨科PEM通常会带来可读性挑战,超过推的等级水平.
研究的目的:
- 为了评估儿童败血性关节炎在线PEMs的可读性.
- 评估这些材料是否符合已建立的可读性准则.
- 分析来自美国顶级儿科整形医院的内容.
主要方法:
- 搜索了美国前25家儿科整形医院的相关PEM的网站.
- 通过使用八个标准化可读性指标分析了12个合格的PEM.
- 与医院排名相关的弗莱什-金凯德等级水平 (FKGL).
主要成果:
- 平均可读性为10.6年级水平,明显高于推的六年级水平.
- 没有一个PEM符合推的可读性标准.
- 七个PEM写在八年级阅读水平以上,而五个 (41.7%) 在八年级阅读水平或以下,经常使用第三方内容.
结论:
- 很大一部分顶级儿科整形医院没有为败血性关节炎提供可访问的PEMs.
- 在线可用的关于儿科败血性关节炎的信息经常超过推的可读性水平.
- 实施简单的语言,外部评论或人工智能辅助编辑可以改善材料的可访问性和健康公平性.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
284
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Health Literacy
5.4K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
5.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
323
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Drug Dosing: Infants and Children
337
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337
Pharmacokinetics in Pediatric Patients: Drug Metabolism
256
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Pediatric Patients: Drug Distribution
335
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335


